Peter Mogayzel

Professor

1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Peter Mogayzel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Cystic Fibrosis Medicine & Life Sciences
Lung Medicine & Life Sciences
Lung Transplantation Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Mucociliary Clearance Medicine & Life Sciences
Cystic Fibrosis Transmembrane Conductance Regulator Medicine & Life Sciences
Guidelines Medicine & Life Sciences
Elastin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

Nutritional Status
Cystic Fibrosis
Feeding Behavior
Child Behavior
Food

Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR

Donaldson, S. H., Laube, B. L., Corcoran, T. E., Bhambhvani, P., Zeman, K., Ceppe, A., Zeitlin, P. L., Mogayzel, P., Boyle, M., Locke, L. W., Myerburg, M. M., Pilewski, J. M., Flanagan, B., Rowe, S. M. & Bennett, W. D., Dec 20 2018, In : JCI insight. 3, 24

Research output: Contribution to journalArticle

Mucociliary Clearance
Cystic Fibrosis
Lung
Sweat
Forced Expiratory Volume

Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic Fibrosis

Bennett, W. D., Zeman, K. L., Laube, B. L., Wu, J., Sharpless, G., Mogayzel, P. & Donaldson, S. H., Aug 1 2018, In : Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31, 4, p. 204-211 8 p.

Research output: Contribution to journalArticle

Mucociliary Clearance
Aerosols
Cystic Fibrosis
Lung
Therapeutics
Cystic Fibrosis
Mutation
Therapeutics
Sweat
ivacaftor

Rare loss of function variants in candidate genes and risk of colorectal cancer

NHLBI GO Exome Sequencing Project, Pulmonary Arterial Hypertension (PAH), Severe Asthma Research Program (SARP), Women’s Health Initiative (WHI), Anthropometry Project Team, Blood Count/Hematology Project Team, Blood Pressure Project Team, Data Flow Working Group, Early MI Project Team, ELSI Working Group, Executive Committee, Family Study Project Team, Lipids Project Team, Lung Project Team, Personal Genomics Project Team, Phenotype and Harmonization Working Group, Population Genetics and Statistical Analysis Working Group, Publications and Presentations Working Group, Quantitative Analysis Ad Hoc Task Group, Sequencing and Genotyping Working Group & 15 others, Steering Committee, Stroke Project Team, Structural Variation Working Group, Subclinical/Quantitative Project Team, Acute Lung Injury (ALI), Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study (CHS), Chronic Obstructive Pulmonary Disease (COPDGene), Coronary Artery Risk Development in Young Adults (CARDIA), Cystic Fibrosis (CF), Early Pseudomonas Infection Control (EPIC), Framingham Heart Study (FHS), Jackson Heart Study (JHS), Lung Health Study (LHS) & Multi-Ethnic Study of Atherosclerosis (MESA), Oct 1 2018, In : Human Genetics. 137, 10, p. 795-806 12 p.

Research output: Contribution to journalArticle

Polyps
Colorectal Neoplasms
Genes
Penetrance
Genetic Testing